Medistim ASA

OSE:MEDI.OL

204 (NOK) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) NOK.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 526.364486.262417.817356.208356.914323.01296.054262.673249.97214.251190.333181.974159.619156.801156.87140.29126.85397.59980.76575.368
Cost of Revenue 298.534106.48697.11476.57780.13979.3872.78264.95864.65355.57249.18949.44242.24242.77642.79240.62237.965000
Gross Profit 227.83379.776320.703279.631276.775243.63223.272197.715185.317158.679141.144132.532117.377114.025114.07899.66888.88897.59980.76575.368
Gross Profit Ratio 0.4330.7810.7680.7850.7750.7540.7540.7530.7410.7410.7420.7280.7350.7270.7270.710.701111
Reseach & Development Expenses 2913.914.514.67.86.46.45.74.27.1527.153000000000
General & Administrative Expenses 42.16731.03228.46223.92120.49219.71440.59616.25716.10610.97210.96111.021051.16351.69642.37337.671000
Selling & Marketing Expenses 9.7178.5064.1033.1057.9186.8294.3876.054.4175.5666.3535.25700000000
SG&A 67.38839.53832.56527.02628.4126.54344.98322.30720.52316.53817.31416.278051.16351.69642.37337.671000
Other Expenses 225.505198.989171.863157.12158.598143.109157.801119.054111.78898.7888.22575.12693.5142.34733.8632.9431.221.2821.2590.849
Operating Expenses 96.388238.527204.428184.146187.008169.652157.801141.361132.311115.318105.53991.40493.51489.82185.55675.31368.8911.2821.2590.849
Operating Income 131.442141.251116.27895.48589.76873.97765.4756.35550.25743.36235.60541.12723.86424.20428.52224.35519.99796.31779.50674.519
Operating Income Ratio 0.250.290.2780.2680.2520.2290.2210.2150.2010.2020.1870.2260.150.1540.1820.1740.1580.9870.9840.989
Total Other Income Expenses Net 3.774.798-2.207-3.8781.2760.5011.141-2.8272.6391.5311.8830.524-1.6020.3978.682-2.755-1.089000
Income Before Tax 135.212146.049114.07191.60791.04474.47966.61253.52755.64544.89237.48841.65222.26124.60137.20421.618.908000
Income Before Tax Ratio 0.2570.30.2730.2570.2550.2310.2250.2040.2230.210.1970.2290.1390.1570.2370.1540.149000
Income Tax Expense 31.38932.07723.17122.21920.73817.42319.03814.42915.22313.64710.95211.4056.7735.9449.3318.0639.485000
Net Income 103.823113.97390.969.38770.30657.05547.57439.09840.42231.24526.53630.24715.48818.65727.87413.53728.393000
Net Income Ratio 0.1970.2340.2180.1950.1970.1770.1610.1490.1620.1460.1390.1660.0970.1190.1780.0960.224000
EPS 5.686.254.993.813.873.142.622.152.231.731.471.660.851.021.510.761.510.950.630.47
EPS Diluted 5.676.244.983.83.863.132.622.152.231.731.471.660.851.021.510.761.510.950.630.47
EBITDA 155.099169.46137.676114.894109.48987.36380.33765.60472.30853.91145.53347.93233.82338.65451.44336.63426.57799.62681.56576.168
EBITDA Ratio 0.2950.3480.330.3230.3070.270.2710.250.2890.2520.2390.2630.2120.2470.3280.2610.211.0211.011.011